- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Lauren S. Gennett
Event 7 results
Webinar
August 26, 2021
Post-Acute Care False Claims Act Trends
Speaking Engagement
July 13, 2021
Amy Boring, Lauren Gennett, Isabella Wood to Speak on Health Care Compliance Association Webinar
Speaking Engagement
July 16, 2020
Isabella Wood, Lauren Gennett to Speak on Lorman Webinar
Speaking Engagement
October 10, 2019
Lauren Gennett, Amy O’Neill to Speak on HCCA Webinar About Developments and Strategies for Extrapolated Overpayments
Webinar
April 19, 2017
Post-Acute Care Enforcement Priorities and Compliance Strategies: Are You Ready for Scrutiny?
Conference
July 14, 2015
CMS’s 2016 OPPS Proposed Rule: Changes to the Two Midnight Rule and Patient Status Reviews
Conference
October 27, 2014
Compliance Lessons Learned from Recent Corporate Integrity Agreement Developments